EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan

Shingo Hatakeyama iD, Hiroyuki Yamamoto iD, Hiroshi Kitamura, Toshiyuki Kamoto, Eiji Kikuchi iD

Cancer Medicine · 2025-08 · 14 (15)

DOI: 10.1002/cam4.71109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 02.08.2025. Verfasst von Shingo Hatakeyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Database Steering Committee of Japanese Urological Association, Tokyo, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Robotic Surgical Procedures, Postoperative Complications. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Japanese Urological Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radical cystectomy (RC) is a standard‐of‐care treatment for muscle‐invasive bladder cancer (MIBC). However, there is a lack of data comparing the benefit of robot‐assisted radical cystectomy (RARC) with laparoscopic radical cystectomy (LRC) or open radical cystectomy (ORC) in Japan. We aimed to explore the safety of RARC compared with that of LRC or ORC using the Japanese National Clinical Database (NCD).

Methods

This retrospective study reviewed the data of 17,549 patients with MIBC who underwent radical cystectomy between February 2019 and December 2022 in the Japanese NCD. We compared the postoperative complications within 30 days between the surgical procedures using the Clavien–Dindo classification. Multivariable logistic regression analysis was conducted for grade ≥ 3 postoperative complications.

Results

Overall, 8308, 3101, and 6140 patients underwent RARC, LRC, and ORC, respectively. The rates of any grade and grade ≥ 3 postoperative complications within 30 days were significantly lower in the RARC group than in the ORC group. RARC had no significant difference in grade ≥ 3 postoperative complications in the ileal neobladder. Regarding any grade postoperative complications, RARC had a significantly lower rate of delirium, surgical site infection, sepsis, and gastrointestinal tract leakage than ORC. Multivariable logistic regression analysis revealed that the incidence of grade ≥ 3 postoperative complications was significantly lower in RARC (odds ratio, 0.83; 95% confidence interval, 0.72–0.95).

Conclusions

RARC had a lower complication rate compared with ORC. LRC had comparable outcomes to RARC. The findings of this study contribute to RARC as being the standard treatment for MIBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyRobotic Surgical ProceduresPostoperative ComplicationsHumansMaleFemaleAgedJapanRetrospective StudiesMiddle AgedDatabases, FactualNeoplasm InvasivenessAged, 80 and over

Stichwörter der Autor:innen

bladder cancerlaparoscopic radical cystectomyradical prostatectomyrobot‐assistedsurgery

Autor:innen und Institutionen

  • National Clinical Database Steering Committee of Japanese Urological Association, Tokyo, Japan.
  • Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Faculty of Medicine, Department of Urology, University of Toyama, Toyama, Japan.
  • Faculty of Medicine, Department of Urology, University of Miyazaki, Miyazaki, Japan.
  • Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.

ORCID-Profile: Shingo Hatakeyama, Hiroyuki Yamamoto, Eiji Kikuchi

Förderung

  • the Japanese Urological Association

Zitieren

APA

Hatakeyama, S., Yamamoto, H., Kitamura, H., Kamoto, T., & Kikuchi, E. (2025). Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan. Cancer Medicine, 14(15). https://doi.org/10.1002/cam4.71109

Vancouver

Hatakeyama S, Yamamoto H, Kitamura H, Kamoto T, Kikuchi E. Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan. Cancer Medicine. 2025;14(15). doi:10.1002/cam4.71109

BibTeX
@article{Hatakeyama2025,
  author = {Hatakeyama, Shingo and Yamamoto, Hiroyuki and Kitamura, Hiroshi and Kamoto, Toshiyuki and Kikuchi, Eiji},
  title = {Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {15},
  doi = {10.1002/cam4.71109}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche